You'll soon find the Dolon team at Prescient.
London, UK – 13th July 2026
Earlier this year, we announced that Dolon had become part of Prescient (Prescient Healthcare Group), bringing together two organisations with complementary expertise, shared values and a commitment to delivering exceptional outcomes for pharmaceutical and biotech clients.
Since then, our teams have been working together, bringing together deep industry experience and connected perspectives to help clients cut through complexity and make confident decisions across the product lifecycle. From 13 August, the Dolon website will become part of the Prescient website.
You’ll continue to find the same team and trusted thought leadership you’ve come to expect from Dolon, now connected with the broader capabilities and specialist offers from Prescient, a strategy-to-impact partner for pharma and biotech across the product lifecycle. Together, Prescient helps pharmaceutical and biotech organisations cut through complexity, build connected strategies and turn stronger decisions into meaningful impact. Bringing everything together on the Prescient website reflects the way our teams already work today, creating a single destination for connected expertise, insights and consulting offers.
What you can expect
Although you’ll notice a new website and brand, the people you know, the relationships you’ve built and the expertise you rely on remain exactly the same.
Our consultants will continue to work alongside you, bringing the same commitment, collaboration and specialist knowledge that has always defined Dolon. They will now be supported by the broader capabilities and specialist expertise of Prescient, giving you access to connected perspectives that bring greater clarity to complexity and support better decision-making across the product lifecycle.
From 13 August, you’ll also find all our latest thought leadership, reports and insights on the Prescient website. Alongside the content you’ve always valued from the Dolon team, you’ll have access to broader expertise and specialist perspectives from across Prescient, making it easier to discover connected thinking, explore new ideas and access the expertise you need through one trusted destination.
Frequently Asked Questions
Why is the Dolon website changing?
Earlier this year, Dolon became part of Prescient. From 13 August, the Dolon website will become part of the Prescient website, bringing our expertise, insights and consulting offers together in one place and making it easier to access the broader capabilities of Prescient.
Will my contacts change?
No. You’ll continue working with the same consultants and specialists who know your business, understand your challenges and remain committed to supporting your success.
What happens to the Dolon website?
From 13 August, the Dolon website will automatically redirect to the Prescient website. Any existing links will take you to the relevant content on the Prescient website wherever possible.
Where can I find future thought leadership?
From 13 August, all new articles, reports, insights and company updates will be published through the Prescient website. You can also follow Prescient on LinkedIn to stay up to date with our latest thinking and news.
Do I need to do anything?
No. If you’re already subscribed to receive updates from Dolon, you’ll continue to receive communications from Prescient. If you’d prefer not to receive future emails, you can unsubscribe at any time using the link included in our communications.
About the acquisition
Earlier this year, we announced that Dolon had joined Prescient, strengthening Prescient’s strategic pricing and market access capabilities and expanding the support we provide to pharmaceutical and biotech companies across the product lifecycle. Since then, our teams have been working together to combine their strengths and create an even broader offer for clients.
If you’d like to learn more about the acquisition and the vision behind bringing our businesses together, you can read the original announcement below.
Read the acquisition announcement → Prescient acquires Dolon, to enhance its strategic pricing and market access capabilities and expertise across the drug lifecycle
Thank you for being part of the Dolon journey. We’re looking forward to continuing to support you through Prescient and building on everything we’ve achieved together.
